A detailed history of Aigen Investment Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Aigen Investment Management, LP holds 3,950 shares of AZN stock, worth $263,070. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,950
Holding current value
$263,070
% of portfolio
0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$76.67 - $87.62 $302,846 - $346,099
3,950 New
3,950 $307,000
Q1 2022

May 05, 2022

SELL
$55.72 - $67.12 $1.25 Million - $1.51 Million
-22,446 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $1.21 Million - $1.43 Million
22,446 New
22,446 $1.26 Million
Q2 2021

Aug 10, 2021

SELL
$48.42 - $60.18 $3.16 Million - $3.92 Million
-65,193 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$47.16 - $54.44 $1.54 Million - $1.78 Million
32,617 Added 100.13%
65,193 $3.24 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $1.58 Million - $1.89 Million
32,576 New
32,576 $1.63 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.